These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 6437467

  • 1. A randomized study of a semisynthetic heparin analogue and heparin in prophylaxis of deep vein thrombosis.
    Törngren S, Kettunen K, Lahtinen J, Koppenhagen K, Brücke P, Hartl P, Hutter O, Haller U, Lahnborg G, Forsskåhl B.
    Br J Surg; 1984 Nov; 71(11):817-20. PubMed ID: 6437467
    [Abstract] [Full Text] [Related]

  • 2. Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group.
    Br J Surg; 1988 Nov; 75(11):1058-63. PubMed ID: 2905187
    [Abstract] [Full Text] [Related]

  • 3. Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Törngren S, Norén I, Forsskåhl B, Sipilä H.
    Thromb Res; 1983 Jun 01; 30(5):527-34. PubMed ID: 6412390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of perioperative deep vein thrombosis in general surgery: a multicentre double blind study comparing two doses of Logiparin and standard heparin. H.B.P.M. Research Group.
    Liezorovicz A, Picolet H, Peyrieux JC, Boissel JP.
    Br J Surg; 1991 Apr 01; 78(4):412-6. PubMed ID: 1851649
    [Abstract] [Full Text] [Related]

  • 6. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T, Wolf H, Michaelis HC, Wagner W, Hoffmann A, Schmidt A, Beck H.
    Thromb Haemost; 1996 Feb 01; 75(2):246-50. PubMed ID: 8815569
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The case for more active prevention of deep-vein thrombosis after major surgery (author's transl)].
    Hubens A, Peeters R.
    Acta Chir Belg; 1976 Jul 01; 75(4):402-15. PubMed ID: 797205
    [Abstract] [Full Text] [Related]

  • 11. Prevention of thromboembolism with use of recombinant hirudin. Results of a double-blind, multicenter trial comparing the efficacy of desirudin (Revasc) with that of unfractionated heparin in patients having a total hip replacement.
    Eriksson BI, Ekman S, Lindbratt S, Baur M, Bach D, Torholm C, Kälebo P, Close P.
    J Bone Joint Surg Am; 1997 Mar 01; 79(3):326-33. PubMed ID: 9070519
    [Abstract] [Full Text] [Related]

  • 12. Prevention of deep-vein thrombosis after total hip arthroplasty. Comparison of warfarin and dalteparin.
    Francis CW, Pellegrini VD, Totterman S, Boyd AD, Marder VJ, Liebert KM, Stulberg BN, Ayers DC, Rosenberg A, Kessler C, Johanson NA.
    J Bone Joint Surg Am; 1997 Sep 01; 79(9):1365-72. PubMed ID: 9314399
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Prevention of deep-vein thrombosis in patients with gynaecological cancer undergoing radiotherapy. A comparison of calcium heparin and a semisynthetic heparin analogue (author's transl)].
    von Hugo R, Hafter R, Hiller KF, Lochmüller H, Selbmann HK, Graeff H.
    Geburtshilfe Frauenheilkd; 1981 Mar 01; 41(3):179-83. PubMed ID: 7215756
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A multicentre, double-blind, randomized study to compare the safety and efficacy of once-daily ORG 10172 and twice-daily low-dose heparin in preventing deep-vein thrombosis in patients with acute ischaemic stroke.
    Dumas R, Woitinas F, Kutnowski M, Nikolic I, Berberich R, Abedinpour F, Zoeckler S, Gregoire F, Jerkovic M, Egberts JF.
    Age Ageing; 1994 Nov 01; 23(6):512-6. PubMed ID: 9231947
    [Abstract] [Full Text] [Related]

  • 18. [Treatment in a heparin-induced skin reaction with a low-molecular heparin analog].
    Zimmermann R, Harenberg J, Weber E, DeVries JX, Jarass W, Schmidt W.
    Dtsch Med Wochenschr; 1984 Aug 31; 109(35):1326-8. PubMed ID: 6236069
    [Abstract] [Full Text] [Related]

  • 19. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Turpie AG, Gent M, Côte R, Levine MN, Ginsberg JS, Powers PJ, Leclerc J, Geerts W, Jay R, Neemeh J.
    Ann Intern Med; 1992 Sep 01; 117(5):353-7. PubMed ID: 1503326
    [Abstract] [Full Text] [Related]

  • 20. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial.
    Lancet; 1975 Jul 12; 2(7924):45-51. PubMed ID: 49649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.